HPV-11 and HPV-6 are the etiological agents of about 90 % of genital warts (GWs). The intra-typic variability of HPV-11 and its association with infection persistence and GW development remains undetermined. Here, HPV infection in men (HIM) participants who had an HPV-11 genital swab and/or GW, preceded or not by a normal skin genital swab were analysed. Genomic variants were characterized by PCR-sequencing and classified within lineages (A, B) and sublineages (A1, A2, A3, A4). HPV-11 A2 variants were the most frequently detected in the genital swab samples from controls and in both genital swabs and GW samples from cases. The same HPV-11 variant was detected in the GW sample and its preceding genital swab. There was a lack of association between any particular HPV-11 variant and the increased risk for GW development.
Genital warts (GWs) constitute one of the most frequently sexually transmitted diseases worldwide [1] . They affect both men and women, frequently in a recurrent manner that demands repeated treatment which represents high medical costs and personal emotional distress [2] . Approximately 90 % of GWs are etiologically associated with lowrisk HPV-6 and HPV-11. HPV-11 infections alone are responsible for 20 % of anogenital warts and up to 30 % of laryngeal papillomas, the latter having a more aggressive and widespread phenotype when compared to its HPV-6-positive counterparts [3] . HPV-11 is a viral type closely related to HPV-6 and is classified within the Alphapapillomavirus species 10. The genomic heterogeneity of HPV types is categorized according to genome-wide nucleotide variations of 1.0-10.0 and 0.5-1.0 %, which define HPV variant lineages and sublineages, respectively. Complete genome analysis of 78 HPV-11 isolates collected throughout the world revealed two variant lineages (lineages A and B) and four sublineages (sublineages A1, A2, A3 and A4) [4] . Furthermore, it was shown that sublineage A2 HPV-11 variants predominate globally, followed by sublineages A1, A3 and A4, and lineage B. HPV molecular variants have been shown to be differentially associated with disease outcome for some high-risk HPV types [5] [6] [7] . Regarding the low-risk viral types' association with disease onset, we recently described the distribution of HPV-6 variants in normal genital skin swabs and GW biopsies obtained from men enrolled in the multinational HPV infection in men (HIM) cohort study [8] . We observed that although HPV-6 B3 variants were predominantly detected on normal genital skin, the frequency of B1 variants was higher in men with a GW compared to those who did not develop a GW. Most importantly, we showed, for the first time, that HPV-6 B1 variants are associated with an increased risk of GW development (OR=1.98, 95 % CI=1.04, 3.80; P=0.04) when compared to B3 variants.
The epidemiological relevance of HPV-11 infection, its role on disease onset and the fact that among HIM participants 22 % of genital HPV-11 infections progressed to an HPV-11-positive GW during the first 12 months of follow-up [9] , prompted us to assess the influence of HPV-11 variability upon GW development among men from Brazil, Mexico and the USA enrolled in the study. Details of the HIM study's design and procedures have been previously published [10, 11] . The study was approved by the ethnical review boards of the Institutional Review Boards at the University of South Florida (Tampa, FL), The Ludwig Institute for Cancer Research (São Paulo Branch, Brazil), the Centro de Referência e Treinamento em DST/Aids (São Paulo, Brazil) and the Instituto Nacional de Salud Publica (Cuernava, Mexico), and informed consent was obtained from all participants.
In the present study we included 52 men who had an HPV-11-positive normal genital skin swab at any bi-annual study visit between April 2009 and December 2013, yet, did not develop any HPV-11 associated GW (categorized as controls). In addition, we analysed 47 cases with an incident HPV-11-positive GW (categorized as cases): 21 men were HPV-11 positive in both the GW and a normal genital skin swab collected prior to lesion development, while 26 cases were HPV-11 negative in all preceding swabs. We may hypothesize that among the cases that did not have an HPV-11-positive swab prior to GW development, infections progressed to GWs during the short time frame between study visits. Alternatively, it is conceivable that latent and/ or persistent infection remained subclinical at low-copy number and thus undetectable. Sociodemographic and sexual behaviour characteristics were compared among cases and controls using the exact Pearson 2 test. None of the variables evaluated significantly differed between cases and controls ( Table 1 ).
For HPV-11 variant characterization, we amplified by PCR and sequenced a 274 bp fragment of the E2/NCR2 regions (3561-3833), which was shown to be representative of whole-genome-based phylogenetic clustering [4] . This enabled the discrimination of the two lineages (A and B) and four sublineages (A1-A4) of HPV-11 when DNA sequences were compared to the HPV-11 prototype (GenBank accession number M14119). Due to PCR failure, we were unable to characterize the infecting variant of five controls and cases, and thus the following analysis were restricted to 47 controls and 42 cases. Fisher's exact test was used to compare the distribution of HPV-11 variants in normal genital skin swabs from the controls and cases, and in GWs of cases by age and country. For these analyses, we assessed the most recent swab of normal genital skin obtained from controls, and prior to GW development among cases. Additionally, Fisher's exact test was used to study the association between HPV-11 variant detection in GWs and the preceding normal genital skin swabs. Variants from the B lineage and A3-A5 sublineages were not identified in any of the specimens analysed. HPV-11 A2 variants were, by far, the most frequently detected in genital swabs from both cases and controls independent of the country, age group or education ( Table 2 ). Variants from the A1 sublineage were detected in 13 % (6/47) of the most recent HPV-11-positive swab of normal genital skin obtained from controls, and in 19 % (4/21) of the swabs collected prior to GW development from cases (P=0.49). HPV-11 A2 variants were also the most frequently detected in GW biopsies independent of the age or country of origin of the participant. Interestingly, for all cases lacking a preceding HPV-11-positive normal genital swab, the GW harboured a B2 variant. Among cases, nearly all genital swabs preceding GW development contained the same variant detected in the lesion (3/3 of A1, and 17/18 of A2 cases; P=1.00). In one case whereas the HPV-11 A1 variant was detected in the normal genital swab, the A2 variant was present in the GW biopsy.
Finally, exact odds' ratios (ORs) and 95 % confidence intervals (CIs) were estimated for the risk of GW according to HPV-11 variant status in the most recent normal genital swab prior to lesion development. We observed no differences in genital wart risk by HPV-11 variant status (A1 vs A2 -OR=1.6, 95 % CI=0.29, 7.76; P=0.74) ( Table 3) .
Our results corroborate previous data reporting that the majority of HPV-11 variants in different anatomical sites cluster into the A2 sublineage globally, and supports that there are no geographically specific variants for this viral type [4, [12] [13] [14] . Additionally, our findings are consistent with other reports that did not observe an association of specific HPV-11 variants with clinical disease [4, 14, 15] . Nevertheless, to the best of our knowledge, this is the first study to investigate prospectively the influence of HPV-11 nucleotide heterogeneity upon the development of GWs in men. The lack of association between the risk of GW development and the detection of a given HPV-11 variant in this study is in contrast to our data regarding HPV-6 diversity [8] . This may be explained by the higher conservation of HPV-11 compared to HPV-6. While the maximum pairwise nucleotide difference between the two most variable genomes is similar among both types (1.6 % for HPV-6 vs 1.3 % for HPV-11), this variability correlates with a higher change in amino acid positions among HPV-6 variants (6.6 %) in comparison with HPV-11 isolates (3.0 %) [4, 15, 16] . We may not exclude the fact that the increased diversity and amino acid changes observed in HPV-6 compared to HPV-11 could just be due to the fact that many more HPV-6 were sequenced. Although no functional comparison between E1/E2 proteins of HPV-6 and HPV-11 has been conducted, one may suppose that the higher diversity of HPV-6 isolates could impact greater divergence in the transcription or replication efficiencies of these variants, and ultimately influence differences in the clinical behaviour. Alternatively, the greater number of HPV-6 samples analysed (151 controls and 98 cases) could have in part contributed to the discrepant findings concerning these closely related viral types.
In summary, the results of this study suggest a lack of association between HPV-11 nucleotide variability and GW development in the male genitalia, and point towards more complex viral-host interactions underlying why some HPV-11 infections progress to GWs while others do not. 
